The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60

Cell Death and Disease

Volumn 2, Issue 10, 2011, Pages

  Chaiwatanasirikul, K A ^a   Sala, A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AKT; Apolipoprotein J; Apoptosis; HSP60; Neuroblastoma; NF b

Indexed keywords

CLUSTERIN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; CHAPERONIN; ISOPROTEIN;

ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; ANIMAL; APOPTOSIS; CELL TRANSFORMATION; FEMALE; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PRESCHOOL CHILD;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CHAPERONIN 60; CHILD, PRESCHOOL; CLUSTERIN; FEMALE; HUMANS; MALE; MICE; PROTEIN ISOFORMS; TRANSFECTION;

EID: 80054985303     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.99     Document Type: Article

References (32)

1. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W et al. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 2006; 13: 12-19.
2. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002; 34: 427-431. (Pubitemid 34242756)
3. McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ et al. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 2000; 106: 1105-1113.
4. Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, Fryer JD et al. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 2001; 7: 338-343. (Pubitemid 32224350)
5. Gleave M, Chi KN. Knock-down of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancers. Ann NY Acad Sci 2005; 1058: 1-15.
6. Jun HO, Kim DH, Lee SW, Lee HS, Seo JH, Kim JH et al. Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3beta signaling pathway. Exp Mol Med 2011; 43: 53-61.
7. Koch-Brandt C, Morgans C. Clusterin: a role in cell survival in the face of apoptosis? Prog Mol Subcell Biol 1996; 16: 130-149.
8. Miyake H, Hara I, Gleave ME. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic. Int J Urol 2005; 12: 785-794. (Pubitemid 41726972)
9. Miyake H, Hara I, Kamidono S, Gleave ME, Eto H. Resistance to cytotoxic chemotherapyinduced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol Rep 2003; 10: 469-473.
10. Sallman DA, Chen X, Zhong B, Gilvary DL, Zhou J, Wei S et al. Clusterin mediates TRAIL resistance in prostate tumor cells. Mol Cancer Ther 2007; 6: 2938-2947. (Pubitemid 350206772)
11. Shim YJ, Shin YJ, Jeong SY, Kang SW, Kim BM, Park IS et al. Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation. Neuroreport 2009; 20: 435-439.
12. Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 2000; 25: 95-98. (Pubitemid 30122416)
13. Wyatt AR, Yerbury JJ, Berghofer P, Greguric I, Katsifis A, Dobson CM et al. Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell Mol Life Sci 2011; e-pub ahead of print 20 April 2011.
14. Ammar H, Closset JL. Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 2008; 283: 12851-12861.
15. Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cell Signal 2009; 21: 704-711.
16. Criswell T, Beman M, Araki S, Leskov K, Cataldo E, Mayo LD et al. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor. J Biol Chem 2005; 280: 14212-14221. (Pubitemid 40517323)
17. Jo H, Jia Y, Subramanian KK, Hattori H, Luo HR. Cancer cell-derived clusterin modulates the phosphatidylinositol 30-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation. Mol Cell Biol 2008; 28: 4285-4299. (Pubitemid 351904951)
18. Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S et al. Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J Immunol 2006; 177: 6471-6479. (Pubitemid 44628866)
19. Bettuzzi S, Davalli P, Davoli S, Chayka O, Rizzi F, Belloni L et al. Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread. Oncogene 2009; 28: 4344-4352.
20. Chayka O, Corvetta D, Dews M, Caccamo AE, Piotrowska I, Santilli G et al. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. J Natl Cancer Inst 2009; 101: 663-677.
21. Santilli G, Aronow BJ, Sala A. Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity. J Biol Chem 2003; 278: 38214-38219. (Pubitemid 37221710)
22. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006; 25: 6680-6684. (Pubitemid 44657845)
23. Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D et al. Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res 2004; 64: 3126-3136. (Pubitemid 38581413)
24. Caccamo AE, Scaltriti M, Caporali A, D'Arca D, Corti A, Corvetta D et al. Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells. Cell Death Differ 2005; 12: 101-104. (Pubitemid 40090035)
25. Caccamo AE, Scaltriti M, Caporali A, D'Arca D, Scorcioni F, Candiano G et al. Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40- immortalized human prostate epithelial cells. Ann NY Acad Sci 2003; 1010: 514-519. (Pubitemid 38265036)
26. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ et al. Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 2000; 97: 5907-5912. (Pubitemid 30367497)
27. Cappello F, Conway de Macario E, Marasa L, Zummo G, Macario AJ. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 2008; 7: 801-809.
28. Chun JN, Choi B, Lee KW, Lee DJ, Kang DH, Lee JY et al. Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation. PLoS One 2010; 5: e9422.
29. Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, Thomas-Tikhonenko A. Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv Cancer Res 2009; 105: 115-132.
30. Hazzaa SM, Elashry OM, Afifi IK. Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol Oncol Res 2010; 16: 101-109.
31. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C et al. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J Biol Chem 2000; 275: 21055-21060. (Pubitemid 30481795)
32. Cappello F, David S, Peri G, Farina F, Conway de Macario E, Macario AJ et al. Hsp60: molecular anatomy and role in colorectal cancer diagnosis and treatment. Front Biosci (Schol Ed) 2011; 3: 341-351.